IDEAYA Biosciences (IDYA) Long-Term Investments (2019 - 2026)

IDEAYA Biosciences has disclosed Long-Term Investments across 8 years of filings, most recently posting $301.7 million for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $301.7 million, down 15.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $301.7 million (down 15.88% YoY), and the FY2025 annual result was $410.3 million, up 1.1% from the prior year.
• Long-Term Investments came in at $301.7 million for Q1 2026 at IDEAYA Biosciences, down from $410.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $410.3 million in Q4 2025 to a low of $7.7 million in Q3 2022.
• The 5-year median for Long-Term Investments is $242.6 million (2024), against an average of $192.1 million.
• Across the five-year window, Long-Term Investments slumped 93.66% in 2022 and jumped 1966.75% in 2024, its largest moves.
• IDEAYA Biosciences' Long-Term Investments stood at $8.3 million in 2022, then surged by 1192.44% to $107.5 million in 2023, then jumped by 277.55% to $405.8 million in 2024, then grew by 1.1% to $410.3 million in 2025, then decreased by 26.46% to $301.7 million in 2026.
• The last three Long-Term Investments figures came in at $301.7 million (Q1 2026), $410.3 million (Q4 2025), and $350.0 million (Q3 2025), per Business Quant data.